Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
OTHER OTC:BPTH
Total Valuation
Bio-Path Holdings has a market cap or net worth of $1.21M. The enterprise value is $5.60M.
Market Cap$1.21M
Enterprise Value$5.60M
Share Statistics
Bio-Path Holdings has 8.31M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8.31M
Owned by Insiders81.83%
Owned by Instutions3.04%
Financial Efficiency
Bio-Path Holdings’s return on equity (ROE) is -36.46 and return on invested capital (ROIC) is -1118.07%.
Return on Equity (ROE)-3645.80%
Return on Assets (ROA)-499.32%
Return on Invested Capital (ROIC)-1118.07%
Return on Capital Employed (ROCE)-1205.71%
Revenue Per Employee$27,400
Profits Per Employee-$1,051,300
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Path Holdings is -0.27. Bio-Path Holdings’s PEG ratio is 0.02.
PE Ratio-0.27
PS Ratio0.00
PB Ratio9.97
Price to Fair Value9.97
Price to FCF-0.38
Price to Operating Cash Flow-0.38
PEG Ratio0.02
Income Statement
In the last 12 months, Bio-Path Holdings had revenue of $274.00K and earned -$10.51M in profits. Earnings per share was -$12.20.
Revenue$274.00K
Gross Profit$154.00K
Operating Income-$12.40M
Pretax Income-$10.51M
Net Income-$10.51M
EBITDA-12.27M
Earnings Per Share (EPS)-12.20
Cash Flow
In the last 12 months, operating cash flow was -$9.51M and capital expenditures $0.00, giving a free cash flow of -$9.51M billion.
Operating Cash Flow-$9.51M
Free Cash Flow-$9.51M
Free Cash Flow per Share-$1.14
Dividends & Yields
Bio-Path Holdings pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-262.30%
Earnings Yield-365.61%
Stock Price Statistics
Beta-1.05
52-Week Price Change-95.37%
50-Day Moving Average0.27
200-Day Moving Average0.91
Relative Strength Index (RSI)37.96
Average Volume (3m)62.05K
Important Dates
Bio-Path Holdings upcoming earnings date is May 15, 2025, TBA.
Last Earnings DateMar 28, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
Bio-Path Holdings as a current ratio of 1.60, with Debt / Equity ratio of 0.26
Current Ratio1.60
Quick Ratio1.60
Debt to Market Cap0.00
Net Debt to EBITDA0.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Path Holdings has paid $342.72K in taxes.
Income Tax$342.72K
Effective Tax Rate0.00%
Enterprise Valuation
Bio-Path Holdings EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -0.30.
EV to Sales0.00
EV to EBITDA-0.22
EV to Free Cash Flow-0.30
EV to Operating Cash Flow-0.30
Balance Sheet
Bio-Path Holdings has $562.00K in cash and marketable securities with $26.00K in debt, giving a net cash position of -$536.00K billion.
Cash & Marketable Securities$562.00K
Total Debt$26.00K
Net Cash-$536.00K
Net Cash Per Share-$0.06
Tangible Book Value Per Share$0.92
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Path Holdings is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside5900.00%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast79.79%